• Users Online: 732
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| September-October  | Volume 33 | Issue 5  
    Online since June 2, 2021

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
MEDICINE AND SOCIETY
Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure
Anurag Bhargava, Madhavi Bhargava, Ajay Meher
September-October 2020, 33(5):298-301
DOI:10.4103/0970-258X.303111  
India has the largest global burden of new cases of tuberculosis (TB) and deaths due to TB. These occur predominantly in the poor who suffer catastrophic costs during diagnosis and treatment. The National Tuberculosis Elimination Programme has ambitious goals of 80% reduction of incidence of TB, 90% reduction in mortality due to TB by 2025 and 0% occurrence of catastrophic costs to households affected by TB by 2020. The Covid-19 pandemic and the resulting disruption to TB services are expected to worsen the situation. There are gaps in case finding at the peripheral level and access to care at the higher level for patients with TB. An estimated 32% patients with active TB do not access diagnostic services, while catastrophic costs associated with hospitalization are a barrier to access for seriously ill patients. Deaths due to TB in India occur largely at home and not in medical facilities, and are preventable with appropriate inpatient care. The Ayushman Bharat scheme with its Health and Wellness Centres (HWCs) and coverage for inpatient care under the Pradhan Mantri Jan Arogya Yojana (PM-JAY) can facilitate, the achievement of the goals of TB elimination. The HWCs provide an opportunity to close the case-finding gap as first point of contact by enabling sputum transport services to the designated microscopy centres. This will facilitate case detection, reduce diagnostic delays, and decrease community transmission and the incidence of TB. The benefit package of PM-JAY can cover patients with pulmonary TB, inpatient evaluation for other forms of TB, enhance the allocation for treatment and cover management of comorbid conditions such as severe undernutrition, anaemia, HIV and diabetes.
  1,288 122 -
ORIGINAL ARTICLES
Clinicopathological profile and outcome of adult infection-related glomerulonephritis: A prospective follow-up study
S Arivazhagan, D Rajasekar, N Gopalakrishnan, R Sakthirajan, J Dhanapriya, T Dinesh Kumar, T Balasubramanian, N Malathy
September-October 2020, 33(5):260-264
DOI:10.4103/0970-258X.317465  
Background. Infection-related glomerulonephritis (IRGN) in adults is witnessing a dramatic shift in its epidemiology and outcome. Adult IRGN studies are all retrospective in nature, and Indian studies are scarce. Methods. We did this prospective study (September 2016–April 2018) on all patients with biopsy-proven IRGN and age ≥18 years satisfying three of five diagnostic criteria. Patients with persistent hypocomplementaemia (>3 months) were excluded. We did electron microscopy in those without a minimum of three diagnostic criteria and did an extensive search for any occult infection in every patient. Results. Forty-five patients were studied with a mean (SD) follow-up of 45.7 (20) weeks. Their mean age was 41.5 years (18–70 years), with a female preponderance (1:1.25). At presentation, the majority had oedema (100%), oliguria (84.4%), hypertension (80%) and haematuria (77.8%). Of them, 86.7% had renal insufficiency and 35.6% required dialysis. Only 53.3% of them had evidence of antecedent/ current infection, with skin/subcutaneous focus being the most common site. Hypocomplementaemia was present in 82.2% of patients. Salient pathological features were endocapillary proliferation (93.3%), neutrophilic infiltration (88.9%), presence of crescents (17.8%), interstitial infiltration (24.4%), moderate-to-severe interstitial fibrosis with tubular atrophy (IFTA; 15.5%) and underlying diabetic glomerulosclerosis (8.9%). Only 66.7% of patients made complete renal recovery. By logistic regression analysis, the predictors of poor outcome were a requirement for dialysis at presentation (p=0.04) and presence of IFTA (p = 0.03). Conclusion. A proportion of adult IRGN patients progress to chronic kidney disease.
  1,126 114 -
Court evidence via video conferencing by doctors: Savings of time, money and energy
Akash Deep Aggarwal, Didar Singh Walia, Krishan Kumar Aggarwal, Surinder Singh Oberoi, Preetinder Singh, Nikhil Mehta, Charan Kamal
September-October 2020, 33(5):265-270
DOI:10.4103/0970-258X.317478  
Background. Doctors are called to courts to give evidence as experts. This is time-consuming and impedes routine patient care. The court ordered the state to instal a video conferencing system for the benefit of doctors in hospitals for this purpose. We aimed to quantify the costs and benefits of the video conferencing system for doctors to give evidence as expert witness in courts. Methods. We analysed the tele-evidence system at our institution from the societal point of view examining whether the arrangements were positive for the taxpayers and second from the point of view of a cost–break-even analysis. Results. Over a period of 1 year, 482 tele-evidences were recorded from our site. Most of the doctors appearing for court evidence were males (84%) and the majority were in government health services (84.4%). These expert witnesses included specialists (83.8%), followed by super-specialists (10.4%) and non-specialists (5.8%). The subject experts who were called the most were radiologists (19.5%), forensic experts (18.3%), surgeons (18.0%), orthopaedic surgeons (12.4%) and neurosurgeons (6.6%). Average savings per tele-evidence were ₹2620; 181 km of travel was prevented and 4 hours and 12 minutes of time was saved. Conclusions. Given our limited resources, video conferencing saves costs, time and travel.
  837 67 -
EDITORIAL
Covid-19 Pandemic: A spoiler for health research
Sonali Sarkar, Rakesh Aggarwal
September-October 2020, 33(5):257-259
DOI:10.4103/0970-258X.317469  
  637 99 -
OBITUARY
S.M. Chandramohan
Kanagavel Manickavasagam
September-October 2020, 33(5):311-312
DOI:10.4103/0970-258X.311631  
  462 33 -
ORIGINAL ARTICLES
Adjuvant radiation therapy for malignant tumours of the eyelid: Experience from a tertiary cancer centre in India
Sushmita Pathy, Bhanu Prasad Venkatesulu, Supriya Mallick, Suryanarayana S.V. Deo, Bidhu Kalyan Mohanti
September-October 2020, 33(5):271-275
DOI:10.4103/0970-258X.317464  
Background. Tumours of the eyelid are a rare subgroup of neoplasms with varied histology and inherent differences in clinical behaviour. Surgery is the standard of care, and adjuvant radiation therapy (RT) is given in the presence of features suggesting a high risk of local recurrence. The treatment of lymph nodes in the neck is debatable. We reviewed the utility of RT for lymph nodes in the neck in patients with malignant tumours of the eyelid. Methods. We reviewed medical records of all patients with tumours of the eyelid treated at our centre from July 2006 to December 2014 for their demographic, clinical profile, treatment details and outcome. Results. The records of 37 patients were included for analysis, of these 34 underwent surgery and 21 received adjuvant RT. Their median age was 60 (range 30–85) years. Sebaceous cell carcinoma was the most common (50.4%). The median disease-free survival (DFS) was 35 months (95% CI 17.9–52.0). The 1- and 3-year DFS were 82.7% and 45%, respectively. Univariate analysis showed a superior outcome with early stage (T1) tumours (p=0.01), RT dose of ≥60 Gy and those underwent lymph node dissection (p=0.03). The presence of high-risk factors including close or positive margin had an inferior outcome with a trend towards statistical significance (p=0.06). Conclusion. We found a favourable outcome with early T stage, RT dose of ≥60 Gy and lymph node dissection. High-risk histopathological features including close margins and positive lymph nodes merit adjuvant RT including regional lymph nodes.
  434 60 -
REVIEW ARTICLE
Mycobacterium chimaera: A novel pathogen with potential risk to cardiac surgical patients
Ruaridh Buchanan, Anuradha Agarwal, Elizabeth Mathai, Benny P Cherian
September-October 2020, 33(5):284-287
DOI:10.4103/0970-258X.317473  
Mycobacterium chimaera was first described in 2004, coming to prominence in 2011 with reports from across the globe of invasive infections following cardiac surgery. This outbreak was linked to a specific type of heater cooler machine used for cardiac surgery by whole-genome sequencing. We briefly outline what is currently known about this pathogen, highlighting the importance of clinical vigilance and the diagnostic options for the clinician.
  398 61 -
CORRESPONDENCE
Covid warriors: A tag of pride or prejudice?
Nipun Malhotra, Nitesh Gupta, Pranav Ish
September-October 2020, 33(5):315-315
DOI:10.4103/0970-258X.315903  
  415 39 -
CLINICAL CASE REPORTS
Drooping shoulders: A rare manifestation of an uncommon disease
Rishav Bansal, Sumitabh Singh, Sunny Singhal, Gevesh Dewangan, Chandan Jyoti Das, Aparajit Ballav Dey
September-October 2020, 33(5):276-277
DOI:10.4103/0970-258X.317479  
Primary systemic amyloidosis is an uncommon disease which presents with involvement of the kidney, heart, peripheral nervous system and liver. The involvement of skeletal muscles called amyloid myopathy is uncommon. We report a 74-year-old male who presented with progressively drooping shoulders followed by other muscular involvement without other organ involvement as a manifestation of amyloidosis. The patient was managed with melphalan, prednisolone and thalidomide with clinical improvement.
  329 47 -
[email protected]
Global trends in attendance in medical colleges and possible solutions
Varad Puntambekar
September-October 2020, 33(5):306-307
DOI:10.4103/0970-258X.317471  
  343 29 -
SELECTED SUMMARIES
Treatment adherence to tuberculosis: What works
Aravinda Chinnadurai
September-October 2020, 33(5):288-289
DOI:10.4103/0970-258X.317477  
  311 27 -
CORRESPONDENCE
The Covid-19 pandemic as an opportunity for advances in medicine
Ramesh Bijlani
September-October 2020, 33(5):316-316
DOI:10.4103/0970-258X.303112  
  263 33 -
CLINICAL CASE REPORTS
Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy
Ilgin Yildirim Simsir, Banu Sarer Yurekli, Irmak Polat, Fusun Saygili, Baris Akinci
September-October 2020, 33(5):278-280
DOI:10.4103/0970-258X.317476  
The near total lack of subcutaneous fat in congenital generalized lipodystrophy (CGL) leads to the accumulation of fat in ectopic organs and severe insulin resistance, which are associated with serious metabolic abnormalities. Cosmetic aspects of the disease are likely to affect the quality of life (QoL) and physiological well-being in these individuals. Metreleptin, recombinant human leptin, replacement treatment has been shown to have benefits in treating the metabolic abnormalities of CGL. In a patient with CGL caused by a homozygous AGPAT2 pathogenic variant, we examined QoL and mood alterations (depression and anxiety) caused by this chronic disease. Metreleptin replacement treatment led to dramatic metabolic improvement in our patient. It was also was associated with improvements in QoL, depression and anxiety scores. We suggest that there is need for studies to document the benefit of metreleptin replacement treatment on QoL and physiological well-being in patients with CGL.
  244 34 -
LETTER FROM MUMBAI
Letter from Mumbai
Sunil Pandya
September-October 2020, 33(5):309-310
DOI:10.4103/0970-258X.317482  
  252 25 -
CORRESPONDENCE
Critiquing the revised minimum qualifications for promotion of medical teachers in India
Saurabh RamBihariLal Shrivastava, Prateek Saurabh Shrivastava
September-October 2020, 33(5):316-318
DOI:10.4103/0970-258X.317480  
  233 41 -
CLINICAL CASE REPORTS
Dry ice in the eye: A rare occupational hazard!
Rinky Agarwal, Jayanand Urkude, Nawazish Fatma Shaikh, Mousumi Banerjee, Namrata Sharma
September-October 2020, 33(5):281-283
DOI:10.4103/0970-258X.317461  
Superficial corneal foreign bodies (FBs) are a common occupational ocular hazard and can cause visually important astigmatism. A 23-year-old male working in a factory, which produced dry ice (solid carbon dioxide), presented to our emergency unit with symptoms of whitish discolouration of the right cornea for 1 day. Visual acuity in both eyes was 20/20 and slit-lamp examination of the right eye revealed an irregularly shaped whitish superficial FB in the inferior paracentral cornea with surrounding superior nebular opacity. Its gentle removal with a moistened cotton bud revealed an underlying epithelial defect with residual whitish changes. At 1-month of follow-up, the patient had nebulo-macular corneal opacity with stromal thinning at the site of impacted dry ice. We speculate that dry ice causes corneal damage due to its extremely cold temperatures and the formation of carbonic acid.
  227 30 -
SELECTED SUMMARIES
Adding ovarian suppression to tamoxifen for pre-menopausal breast cancer
Abhenil Mittal, Ajay Gogia
September-October 2020, 33(5):289-290
DOI:10.4103/0970-258X.317474  
  224 33 -
LETTER FROM LONDON
Letter from London
Anna Ruddock
September-October 2020, 33(5):308-308
DOI:10.4103/0970-258X.317481  
  221 21 -
CLINICAL RESEARCH METHODS
Primer of Epidemiology 3: An overview and observational study designs
Poornima Prabhakaran, Roopa Shivashankar
September-October 2020, 33(5):291-297
DOI:10.4103/0970-258X.317472  
  203 37 -
MEDICINE AND SOCIETY
Perceptions of a university’s faculty members on organ donation
Nisha Yadav, Meena Jain, Ankur Sharma, Vishal Jain, Puneet Chahar, Neha Verma
September-October 2020, 33(5):302-305
DOI:10.4103/0970-258X.317462  
Background. Availability of donated organs may save lives of people with end-stage disease. However, multiple barriers exist for obtaining donated organs such as insufficient knowledge and lack of a positive attitude towards organ donation. We assessed the knowledge and attitude regarding organ donation among faculty members of a university in India. Methods. We did this observational, cross-sectional study from December 2017 to January 2018. A structured, close-ended questionnaire consisting of 20 items was used to assess knowledge, attitude and practices regarding organ donation. Data for 170 participants were analysed using SPSS version 21. Unpaired t-test was used to compare the knowledge and attitude score among different variables. Results. A statistically significant difference was found between the attitude score of graduate and postgraduate faculty (p=0.003), as well as between graduate and doctoral faculty (p=0.001). We found that 5.3% of participants had already donated organs, 12.9% had pledged to donate and 63.5% of participants had expressed willingness to donate organs. Conclusions. There is a need to increase the knowledge regarding organ donation as most people have a good attitude towards organ donation, but their knowledge was insufficient and at times inaccurate.
  195 29 -
IMAGES IN MEDICINE
Anatomical absence of the anterior communicating artery
Navneet Ateriya, Devendra Jadav, Raghvendra Singh Shekhawat
September-October 2020, 33(5):314-314
DOI:10.4103/0970-258X.317470  
  190 24 -
Cyclic oculomotor palsy in a young male
Adarsh Shashni, Pradeep Sharma, Nripen Gaur, Swati Phuljhele
September-October 2020, 33(5):313-313
DOI:10.4103/0970-258X.317463  
  178 24 -
NEWS FROM HERE AND THERE
BMJ awards 2020 for outstanding individuals and best research paper

September-October 2020, 33(5):319-320
DOI:10.4103/0970-258X.317483  
  133 34 -